Abstract
We report on a patient who received a diagnosis of HIV infection following kidney transplantation some years earlier. As a result of intolerance and failure of nucleoside and non-nucleoside reverse transcriptase inhibitor (NRTI and NNRTI)-containing regimens, he was started on Kaletra® single agent HAART. Kaletra® was well tolerated and resulted in sustained viral load suppression below the limit of detection for at least 36 months.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schürmann, D., Wesselmann, H., Kurowski, M. et al. Kaletra® Single Agent HAART after Intolerance of NRTI- and NNRTI-Containing Regimens Following Kidney Transplantation. Infection 35, 194 (2007). https://doi.org/10.1007/s15010-007-6084-1
Received:
Accepted:
DOI: https://doi.org/10.1007/s15010-007-6084-1